Galectin Therapeutics Inc. (GALT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Galectin Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.62x | -1.71x | -2.43x | -1.73x | -3.97x | -5.44x |
| P/B Ratio | -2.11x | -0.78x | -1.66x | -2.08x | 46.31x | 5.28x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.42x | 0.49x | 1.77x | 1.58x | 4.63x | 5.46x |
| Quick Ratio | 2.42x | 0.49x | 1.77x | 1.58x | 4.63x | 5.46x |
| Leverage | ||||||
| Debt/Equity | -1.06x | -1.03x | -1.19x | -1.24x | 11.11x | 0.00x |
YoY = year-over-year change. Source: FMP..